Liminatus Pharma annual meeting draws 48.31% of shares represented
LIMN•Annual meeting results
Liminatus Pharma held its 2026 annual shareholder meeting on Aug. 3, 2026.
- Shareholders ratified Withum Smith+Brown PC as independent registered public accounting firm for fiscal 2026.
- Investors authorized the board to pursue a reverse stock split of up to 1-for-50.
- The charter amendment tied to the reverse split authorization was also adopted.
- The reverse split ratio, timing, and execution remain at the board’s discretion.
